Meristem Family Wealth, LLC Zoetis Inc. Transaction History

Meristem Family Wealth, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$148.29 - $182.55 $626,080 - $770,726	-4,222 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$181.39 - $234.03 $313,986 - $405,105	-1,731 Reduced 29.08%	4,222 $796,000
Q3 2021 Nov 15, 2021	BUY	$189.29 - $209.69 $451,267 - $499,900	2,384 Added 66.8%	5,953 $1.16 Million
Q2 2021 Aug 06, 2021	BUY	$155.9 - $187.99 $338,303 - $407,938	2,170 Added 155.11%	3,569 $665,000
Q1 2021 May 12, 2021	SELL	$144.0 - $169.39 $720 - $846	-5 Reduced 0.36%	1,399 $220,000

Q4 2020 Feb 12, 2021	BUY	$157.07 - $174.35 $10,994 - $12,204	70 Added 5.25%	1,404 $232,000
Q3 2020 Nov 13, 2020	BUY	$137.1 - $165.37 $182,891 - $220,603	1,334 New	1,334 $221,000

1,859

416M

1.13M

1.81M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.2B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Meristem Family Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Meristem Family Wealth, LLC with notifications on news.